The SA Journal Diabetes & Vascular Disease Volume 19 No 1 (July 2022)

NEW INTRODUCING OUR PERINDOPRIL TERT-BUTYLAMINE/ INDAPAMIDE *FDC THE ENDURANCE ACE- i For further product information contact PHARMA DYNAMICS Email info@pharmadynamics.co.za CUSTOMER CARE LINE +27 21 707 7000 www.pharmadynamics.co.za PEARINDA PLUS 8. Each tablet contains 8 mg perindopril tert -butylamine and 2,5 mg indapamide. S3 A49/7.1.3/0013. For full prescribing information, refer to the professional information approved by SAHPRA, 20 April 2021. 1) Data on file. 2) Mourad JJ and Le Jeune S. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients. Current Medical Research and Opinion 2009;25(9):2271-2280. 3) Telejko E, Perindopril arginine: Benefits of a new salt of the ACE inhibitor perindopril. Current Medical Research and Opinion 2007;23(5):953-960. *FDC – Fixed-dose combination. PAC960/08/2022. ATHLETE: AJ Calitz – CHAMPION TRAIL RUNNER Perindopril/Indapamide has shown2: • Incremental dose e„cacy • Increased BP responder rates • Proven outcomes PERINDOPRIL TERT-BUTYLAMINE 8 mg IS EQUIVALENT TO PERINDOPRIL ARGININE 10 mg3 FORMULARY LISTINGS1 DISCOVERY HEALTH Executive/Comprehensive Core/Saver/Priority Keycare MRP MMI      PERINDOPRIL TERT-BUTYLAMINE/ INDAPAMIDE 8/2,5 mg

RkJQdWJsaXNoZXIy NDIzNzc=